Xlife Sciences Financials
| XLS Stock | 21.10 0.10 0.48% |
Xlife |
Understanding current and past Xlife Sciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Xlife Sciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Xlife Sciences' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Xlife Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Xlife Sciences AG. Check Xlife Sciences' Beneish M Score to see the likelihood of Xlife Sciences' management manipulating its earnings.
| Foreign Associate | USA |
| Instrument | Switzerland Stock View All |
| Exchange | SIX Swiss Exchange |
| ISIN | CH0461929603 |
| Business Address | Talacker 35, Zurich, |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.xlifesciences.ch |
| Phone | 41 44 385 84 60 |
You should never invest in Xlife Sciences without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Xlife Stock, because this is throwing your money away. Analyzing the key information contained in Xlife Sciences' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Xlife Sciences Key Financial Ratios
There are many critical financial ratios that Xlife Sciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Xlife Sciences AG reports annually and quarterly.Xlife Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Xlife Sciences's current stock value. Our valuation model uses many indicators to compare Xlife Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Xlife Sciences competition to find correlations between indicators driving Xlife Sciences's intrinsic value. More Info.Xlife Sciences AG is rated first in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Xlife Sciences' earnings, one of the primary drivers of an investment's value.Xlife Sciences AG Systematic Risk
Xlife Sciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Xlife Sciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Xlife Sciences AG correlated with the market. If Beta is less than 0 Xlife Sciences generally moves in the opposite direction as compared to the market. If Xlife Sciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Xlife Sciences AG is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Xlife Sciences is generally in the same direction as the market. If Beta > 1 Xlife Sciences moves generally in the same direction as, but more than the movement of the benchmark.
Xlife Sciences January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Xlife Sciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Xlife Sciences AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of Xlife Sciences AG based on widely used predictive technical indicators. In general, we focus on analyzing Xlife Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Xlife Sciences's daily price indicators and compare them against related drivers.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 21.7 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 8.33 |
Additional Tools for Xlife Stock Analysis
When running Xlife Sciences' price analysis, check to measure Xlife Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xlife Sciences is operating at the current time. Most of Xlife Sciences' value examination focuses on studying past and present price action to predict the probability of Xlife Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xlife Sciences' price. Additionally, you may evaluate how the addition of Xlife Sciences to your portfolios can decrease your overall portfolio volatility.